GPRASP2
Basic information
Region (hg38): X:102712445-102717733
Links
Phenotypes
GenCC
Source:
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome (Supportive), mode of inheritance: XL
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, X-linked, 7 | XL | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Craniofacial | 28096187 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPRASP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 31 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 1 | 31 | 14 | 8 |
Variants in GPRASP2
This is a list of pathogenic ClinVar variants found in the GPRASP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-102714234-A-G | Benign (May 12, 2021) | |||
X-102714835-G-A | Benign (May 20, 2021) | |||
X-102714903-G-C | not specified | Uncertain significance (Feb 06, 2024) | ||
X-102714932-G-C | GPRASP2-related disorder • not specified | Uncertain significance (Feb 17, 2022) | ||
X-102714939-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
X-102715009-G-C | GPRASP2-related disorder • not specified | Uncertain significance (May 05, 2022) | ||
X-102715045-C-T | not specified | Uncertain significance (May 13, 2024) | ||
X-102715080-G-A | not specified | Uncertain significance (May 30, 2024) | ||
X-102715113-G-T | not specified | Uncertain significance (Jun 29, 2023) | ||
X-102715124-ACCCAAAACGGAGGCTCAAGGAATCACAGGGGCCAGG-A | GPRASP2-related disorder | Uncertain significance (Apr 29, 2024) | ||
X-102715133-G-A | GPRASP2-related disorder | Likely benign (Mar 27, 2019) | ||
X-102715156-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
X-102715165-A-G | not specified | Uncertain significance (May 18, 2022) | ||
X-102715176-A-T | not specified | Uncertain significance (Sep 27, 2022) | ||
X-102715195-G-A | GPRASP2-related disorder | Likely benign (Oct 25, 2021) | ||
X-102715243-AGGCCCAGGCATG-A | Benign (Apr 04, 2018) | |||
X-102715310-G-T | not specified | Uncertain significance (Jan 10, 2023) | ||
X-102715373-C-T | GPRASP2-related disorder | Likely benign (Oct 02, 2019) | ||
X-102715388-A-C | Benign (May 05, 2021) | |||
X-102715454-G-C | GPRASP2-related disorder | Likely benign (Sep 22, 2023) | ||
X-102715567-C-T | GPRASP2-related disorder | Benign (Aug 10, 2022) | ||
X-102715657-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
X-102715671-T-C | not specified | Uncertain significance (May 13, 2024) | ||
X-102715730-G-A | GPRASP2-related disorder | Likely benign (Mar 08, 2019) | ||
X-102715734-A-G | GPRASP2-related disorder | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPRASP2 | protein_coding | protein_coding | ENST00000543253 | 1 | 6504 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.988 | 0.0125 | 125734 | 0 | 8 | 125742 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.713 | 270 | 305 | 0.885 | 0.0000217 | 5552 |
Missense in Polyphen | 43 | 68.962 | 0.62353 | 1392 | ||
Synonymous | 1.17 | 99 | 115 | 0.861 | 0.00000859 | 1642 |
Loss of Function | 3.67 | 1 | 17.6 | 0.0567 | 0.00000138 | 309 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000760 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000626 | 0.0000462 |
European (Non-Finnish) | 0.0000613 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000221 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in regulation of a variety of G-protein coupled receptors. {ECO:0000269|PubMed:15086532}.;
Recessive Scores
- pRec
- 0.0850
Intolerance Scores
- loftool
- 0.656
- rvis_EVS
- 0.29
- rvis_percentile_EVS
- 71.5
Haploinsufficiency Scores
- pHI
- 0.0589
- hipred
- N
- hipred_score
- 0.357
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.000130
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gprasp2
- Phenotype
Gene ontology
- Biological process
- Cellular component
- cytoplasm
- Molecular function
- amyloid-beta binding;protein binding